In ₹ Crore except Per Share Latest Annual | THYROCARE FY26 | LALPATHLAB FY26 | METROPOLIS FY26 | VIJAYA FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | ◆ 54.33× | 63.23× | 64.74× | 89.41× | 64.74× -16% | |
| P/B | 15.15× | 12.61× | ◆ 8.09× | 16.16× | 12.61× +20% | |
| EV/EBITDA | 33.17× | 40.10× | ◆ 30.33× | 45.10× | 40.10× -17% | |
| Market Cap | ₹8,882 Cr | ₹32,045 Cr | ₹12,336 Cr | ₹15,465 Cr | ₹15,465 Cr -43% | |
| Growth | ||||||
| Revenue CAGR 3Y | 16.33% | 11.06% | 12.75% | ◆ 21.03% | 12.75% +28% | |
| Revenue CAGR 5Y | 10.88% | 11.81% | 10.52% | ◆ 16.66% | 11.81% -8% | |
| Net Income CAGR 3Y | ◆ 36.27% | 28.35% | 10.06% | 26.62% | 26.62% +36% | |
| Revenue YoY (latest Q) | ◆ 24.34% | 19.10% | 16.62% | 22.83% | 19.10% +27% | |
| Net Income YoY (latest Q) | 34.06% | 27.24% | 25.72% | ◆ 37.61% | 27.24% +25% | |
| Profitability | ||||||
| EBITDA Margin | 31.61% | 28.32% | 24.36% | ◆ 41.38% | 28.32% +12% | |
| Net Income Margin | 19.64% | 18.45% | 11.62% | ◆ 21.24% | 18.45% +6% | |
| Return on Common Equity | ◆ 27.82% | 19.86% | 12.46% | 18.07% | 18.07% +54% | |
| Return on Capital Employed | ◆ 31.92% | 23.03% | 14.81% | 17.72% | 17.72% +80% | |
| Return on Assets | ◆ 21.79% | 16.20% | 8.94% | 11.48% | 11.48% +90% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.00× | 0.00× | 0.01× | 0.00× | 0.00× | |
| Interest Coverage | ◆ 72.66× | 27.22× | 10.88× | 7.38× | 10.88× +568% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹829 Cr | ₹2,763 Cr | ₹1,646 Cr | ₹814 Cr | ₹1,646 Cr -50% | |
| Net Income | ₹163 Cr | ₹510 Cr | ₹191 Cr | ₹173 Cr | ₹191 Cr -15% | |
| Total Assets | ₹747 Cr | ₹3,146 Cr | ₹2,138 Cr | ₹1,507 Cr | ₹2,138 Cr -65% | |
| EPS | ₹10.27 | ₹30.24 | ₹9.19 | ₹16.81 | ₹16.81 -39% | |
| Book Value per Share | ₹36.82 | ₹151.63 | ₹73.53 | ₹93.02 | ₹93.02 -60% | |